Drug Index



Mechanism :

Candesartan selectively blocks the binding of angiotensin II to AT1 in many tissues including vascular smooth muscle and the adrenal glands. This inhibits the AT1-mediated vasoconstrictive and aldosterone-secreting effects of angiotensin II and results in an overall decrease in blood pressure. Candesartan is greater than 10,000 times more selective for AT1 than AT2. Inhibition of aldosterone secretion may increase sodium and water excretion while decreasing potassium excretion.

Indication :

• Hypertension

Contraindications :

Hypersensitivity, Severe hepatic impairment, Do not coadminister with aliskiren in patients with diabetes.

Dosing :

1-6 years: Start with 0.2 mg/kg orally once daily or in two divided doses. Dose range: 0.05-0.4 mg/kg/day orally.

6-17 years, <50 kg: Start with 4-8 mg/day orally once a day. Dose Range:

Adjust within 2 weeks to dose range 2-16 mg/day orally once a day; Max: 32 mg/day.

6-17 years, >50 kg: Start with 8-16 mg/day PO. Dose range: Adjust within 2 weeks to dose range 4-32 mg/day PO; not to exceed 32 mg/day.

Adverse Effect :

Hives, difficulty breathing, angioedema, rhabdomyolysis.

Interaction :

Aliskiren: Increases the toxicity of both the drugs.
ACE Inhibitors: Increases the toxicity by pharmacodynamic synergism.

03/10/2020 06:29:16 Candesartan
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0